8-K
filed May 15, 2024, 7:59 PM ET
ticker CAPR
CIK 0001133869
other
confidence high
sentiment neutral
materiality 0.15
Capricor shareholders approve doubling authorized shares to 100M and elect all nine director nominees
CAPRICOR THERAPEUTICS, INC.
- Amendment to increase authorized common shares from 50M to 100M approved (12.3M for, 8.7M against).
- All nine director nominees elected, including CEO Linda Marbán and Frank Litvack.
- Ratification of Rose, Snyder & Jacobs as auditor for FY 2024 approved (20.3M for).
- Non-binding advisory vote on executive compensation approved (9.2M for, 2.0M against).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Linda Marbán, Ph.D. as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Michael Kelliher as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Frank Litvack, M.D. as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Paul Auwaerter, M.D. as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Karimah Es Sabar as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Earl M. Collier, Jr. as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Philip Gotwals, Ph.D. as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of David B. Musket as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
CAPRICOR THERAPEUTICS, INC. shareholders approved Election of George W. Dunbar, Jr. as director at the 2024-05-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-14
Exact text from the filing
rsuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market Item 5.07 Submission of Matters of a Vote of Security Holders.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.